Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluating the Potential of Polygenic Risk Score to Improve Colorectal Cancer Screening.
Arnau-Collell C, Díez-Villanueva A, Bellosillo B, Augé JM, Muñoz J, Guinó E, Moreira L, Serradesanferm A, Pozo À, Torà-Rocamora I, Bonjoch L, Ibañez-Sanz G, Obon-Santacana M, Moratalla-Navarro F, Sanz-Pamplona R, Márquez Márquez C, Rueda Miret R, Pérez Berbegal R, Piquer Velasco G, Hernández Rodríguez C, Grau J, Castells A, Borràs JM, Bessa X, Moreno V, Castellví-Bel S. Arnau-Collell C, et al. Among authors: ibanez sanz g. Cancer Epidemiol Biomarkers Prev. 2022 Jul 1;31(7):1305-1312. doi: 10.1158/1055-9965.EPI-22-0042. Cancer Epidemiol Biomarkers Prev. 2022. PMID: 35511747 Free PMC article.
Post-polypectomy colonoscopy surveillance: Can we improve the diagnostic yield?
Ibáñez-Sanz G, Sanz-Pamplona R, Garcia M; PhD on behalf of the MSIC-SC research group. Ibáñez-Sanz G, et al. Gastroenterol Hepatol. 2022 Jun-Jul;45(6):474-487. doi: 10.1016/j.gastrohep.2021.11.005. Epub 2021 Nov 27. Gastroenterol Hepatol. 2022. PMID: 34848307 Review. English, Spanish.
False-Positive Results in a Population-Based Colorectal Screening Program: Cumulative Risk from 2000 to 2017 with Biennial Screening.
Ibáñez-Sanz G, Garcia M, Milà N, Hubbard RA, Vidal C, Binefa G, Benito L, Moreno V; Adverse Effects on Colorectal Cancer Screening in Catalonia (EACC) Study Working Group. Ibáñez-Sanz G, et al. Cancer Epidemiol Biomarkers Prev. 2019 Nov;28(11):1909-1916. doi: 10.1158/1055-9965.EPI-18-1368. Epub 2019 Sep 5. Cancer Epidemiol Biomarkers Prev. 2019. PMID: 31488415
Polygenic risk score across distinct colorectal cancer screening outcomes: from premalignant polyps to colorectal cancer.
Obón-Santacana M, Díez-Villanueva A, Alonso MH, Ibáñez-Sanz G, Guinó E, López A, Rodríguez-Alonso L, Mata A, García-Rodríguez A, Palomo AG, Molina AJ, Garcia M, Binefa G, Martín V, Moreno V. Obón-Santacana M, et al. Among authors: ibanez sanz g. BMC Med. 2021 Nov 8;19(1):261. doi: 10.1186/s12916-021-02134-x. BMC Med. 2021. PMID: 34743725 Free PMC article.
Prescription drugs associated with false-positive results when using faecal immunochemical tests for colorectal cancer screening.
Ibáñez-Sanz G, Garcia M, Rodríguez-Moranta F, Binefa G, Gómez-Matas J, Domènech X, Vidal C, Soriano A, Moreno V; ‘Adverse Effects on Colorectal Cancer Screening in Catalonia (EACC) Study’ Working Group. Ibáñez-Sanz G, et al. Dig Liver Dis. 2016 Oct;48(10):1249-54. doi: 10.1016/j.dld.2016.06.011. Epub 2016 Jun 21. Dig Liver Dis. 2016. PMID: 27378703
31 results